Security key
20454B104
Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX)
CUSIP: 20454B104
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 62,376,106
- Total 13F value
- $85,353,000
- Share change
- -1,191,856
- SEC-reported price per share
- $1.37
- Number of holders
- 33
- Value change
- -$4,074,753
- Number of buys
- 12
- Number of sells
- 15
- Shares outstanding
- 180,577,721
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q1 2022
Institutions
33
Top holders
10
CMPX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Compass Therapeutics, Inc. SEC filings
Compass Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 20454B104
Recent filing periods:
Ownership snapshot
Top reported holders of CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
12%
FMR LLC
3.8%
Rock Springs Capital Management LP
3%
Foresite Capital Management V, LLC
2.4%
Consonance Capital Management LP
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
12%
|
$68,608,000
21,642,975 shares
|
— | 31 Dec 2021 |
| FMR LLC |
13F
Company
|
3.8%
|
$21,786,000
6,872,414 shares
|
— | 31 Dec 2021 |
| Rock Springs Capital Management LP |
13F
Company
|
3%
|
$16,890,000
5,328,088 shares
|
— | 31 Dec 2021 |
| Foresite Capital Management V, LLC |
13F
Company
|
2.4%
|
$13,948,000
4,400,000 shares
|
— | 31 Dec 2021 |
| Consonance Capital Management LP |
13F
Company
|
1.9%
|
$11,165,000
3,500,000 shares
|
— | 31 Dec 2021 |
| CHI Advisors LLC |
13F
Company
|
1.7%
|
$9,585,000
3,023,692 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
62,376,106
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
37
Q1 2022 holders
33
Holder diff
-4
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend